Literature DB >> 28915012

Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity.

Eirik Adim Moreb1, Benjamin Hoover1, Adam Yaseen1, Nisakorn Valyasevi1, Zoe Roecker1, Romel Menacho-Melgar1, Michael D Lynch1.   

Abstract

Phage-derived "recombineering" methods are utilized for bacterial genome editing. Recombineering results in a heterogeneous population of modified and unmodified chromosomes, and therefore selection methods, such as CRISPR-Cas9, are required to select for edited clones. Cells can evade CRISPR-Cas-induced cell death through recA-mediated induction of the SOS response. The SOS response increases RecA dependent repair as well as mutation rates through induction of the umuDC error prone polymerase. As a result, CRISPR-Cas selection is more efficient in recA mutants. We report an approach to inhibiting the SOS response and RecA activity through the expression of a mutant dominant negative form of RecA, which incorporates into wild type RecA filaments and inhibits activity. Using a plasmid-based system in which Cas9 and recA mutants are coexpressed, we can achieve increased efficiency and consistency of CRISPR-Cas9-mediated selection and recombineering in E. coli, while reducing the induction of the SOS response. To date, this approach has been shown to be independent of recA genotype and host strain lineage. Using this system, we demonstrate increased CRISPR-Cas selection efficacy with over 10 000 guides covering the E. coli chromosome. The use of dominant negative RecA or homologues may be of broad use in bacterial CRISPR-Cas-based genome editing where the SOS pathways are present.

Entities:  

Keywords:  RecA; RecA56; SOS; cas9; genome editing; recombineering

Mesh:

Substances:

Year:  2017        PMID: 28915012     DOI: 10.1021/acssynbio.7b00174

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  9 in total

1.  The transcription regulator and c-di-GMP phosphodiesterase PdeL represses motility in Escherichia coli.

Authors:  Cihan Yilmaz; Aathmaja Anandhi Rangarajan; Karin Schnetz
Journal:  J Bacteriol       Date:  2020-12-14       Impact factor: 3.490

Review 2.  Barriers to genome editing with CRISPR in bacteria.

Authors:  Justin M Vento; Nathan Crook; Chase L Beisel
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-05       Impact factor: 3.346

3.  Improved sgRNA design in bacteria via genome-wide activity profiling.

Authors:  Jiahui Guo; Tianmin Wang; Changge Guan; Bing Liu; Cheng Luo; Zhen Xie; Chong Zhang; Xin-Hui Xing
Journal:  Nucleic Acids Res       Date:  2018-08-21       Impact factor: 16.971

4.  A novel approach for T7 bacteriophage genome integration of exogenous DNA.

Authors:  Ying Liu; Hongxing Huang; Hua Wang; Yan Zhang
Journal:  J Biol Eng       Date:  2020-01-16       Impact factor: 4.355

5.  Adaptation to mutational inactivation of an essential gene converges to an accessible suboptimal fitness peak.

Authors:  João V Rodrigues; Eugene I Shakhnovich
Journal:  Elife       Date:  2019-10-01       Impact factor: 8.140

6.  A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.

Authors:  Mei-Yi Yan; Si-Shang Li; Xin-Yuan Ding; Xiao-Peng Guo; Qi Jin; Yi-Cheng Sun
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.867

7.  Metabolic engineering of Escherichia coli BL21 strain using simplified CRISPR-Cas9 and asymmetric homology arms recombineering.

Authors:  Sudha Shukal; Xiao Hui Lim; Congqiang Zhang; Xixian Chen
Journal:  Microb Cell Fact       Date:  2022-02-05       Impact factor: 5.328

8.  Akaby-Cell-free protein expression system for linear templates.

Authors:  Wakana Sato; Judee Sharon; Christopher Deich; Nathaniel Gaut; Brock Cash; Aaron E Engelhart; Katarzyna P Adamala
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

9.  Targetron-Assisted Delivery of Exogenous DNA Sequences into Pseudomonas putida through CRISPR-Aided Counterselection.

Authors:  Elena Velázquez; Yamal Al-Ramahi; Jonathan Tellechea-Luzardo; Natalio Krasnogor; Víctor de Lorenzo
Journal:  ACS Synth Biol       Date:  2021-10-02       Impact factor: 5.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.